The Relationship Between COPD and Lung Cancer Explained

They share several risk factors, particularly smoking, and it is possible to have both conditions at the same time. COPD is also associated with an increased risk of developing lung cancer, although having COPD certainly does not mean that cancer is inevitable.

The overlap becomes particularly important when symptoms change, or lung cancer is diagnosed, because existing lung function can influence which treatments can be given safely.

Why Are COPD and Lung Cancer Connected?

COPD is a long-term lung condition characterised by persistent airflow obstruction. It is associated with changes such as emphysema and chronic bronchitis and commonly causes breathlessness, a persistent cough, increased sputum production and recurrent chest infections.

Lung cancer is different. It develops when abnormal cells within the lung grow uncontrollably and form a tumour.

One of the main reasons the two conditions are connected is that they share important risk factors. Smoking is the most significant example. Long-term exposure to tobacco smoke can contribute to the development of COPD while also damaging the DNA within lung cells and increasing the risk of cancer.

There are other factors involved as well. Age, environmental and occupational exposures, chronic inflammation and underlying structural damage within the lungs may all contribute to the relationship.

If cancer is subsequently diagnosed, COPD becomes one of several factors considered when developing an individual lung cancer treatment plan. The condition can affect how well someone tolerates surgery, radiotherapy, or systemic treatments.

Does COPD Increase the Risk of Lung Cancer?

Yes. COPD is associated with an increased risk of lung cancer.

Part of that association is explained by smoking because tobacco exposure is a major risk factor for both diseases. However, the relationship is not thought to be explained by smoking alone.

Long-standing inflammation, repeated injury to lung tissue and structural changes within the lungs may also contribute. Emphysema is particularly relevant. NICE advises that the presence of emphysema on a CT scan should be recognised as an independent risk factor for lung cancer.

This does not mean that COPD will develop into cancer. COPD itself is not cancer, and most people should think about the relationship in terms of increased risk rather than progression from one disease into another.

The broader leading causes of lung cancer include several overlapping influences, including smoking, environmental exposures and previous lung disease.

Similar Symptoms Can Make the Picture Less Clear

One difficulty is that COPD and lung cancer can produce some of the same symptoms.

A persistent cough, breathlessness, fatigue and recurrent chest infections can occur with COPD. They may also occur in someone with lung cancer.

For a person who has lived with COPD for years, gradual fluctuations in breathing or coughing may feel familiar. What matters is recognising a new symptom or a meaningful change from what is normal for that individual.

For example, a cough that changes noticeably, coughing up blood, unexplained weight loss, persistent chest pain or breathlessness that becomes significantly worse deserves appropriate medical assessment rather than automatically being attributed to COPD.

Having an established respiratory diagnosis should not prevent a new or changing symptom from being investigated on its own merits.

COPD and Lung Cancer Are Diagnosed Differently

Although the symptoms can overlap, the investigations used for the two conditions have different purposes.

Clinicians usually assess COPD using spirometry alongside symptoms, medical history, and other investigations. Spirometry measures airflow and can demonstrate the persistent airflow obstruction characteristic of COPD.

Lung cancer cannot be diagnosed through spirometry. Imaging such as chest X-ray and CT may identify abnormalities that require further investigation, while biopsy is often needed to establish the diagnosis. PET-CT may then have an important role in staging the cancer and planning treatment when appropriate.

This distinction matters because breathing tests assess how well the lungs are working, rather than identifying whether a tumour is present.

How COPD Can Affect Lung Cancer Treatment

Having COPD does not automatically exclude someone from potentially curative lung cancer treatment. It does, however, make assessment of respiratory fitness particularly important.

Surgery removes part of the lung, so the remaining lung function needs to be sufficient for the procedure to be considered safe. This is one reason pulmonary function testing is commonly performed when surgery is being considered.

The same principle can apply to radiotherapy. Treatment planning takes account of the tumour's location as well as the amount and condition of surrounding healthy lung tissue. Where lung function is already reduced, careful planning becomes especially important.

Chemotherapy, immunotherapy and targeted treatments may also be considered depending on the type and stage of cancer, tumour biology and the patient's overall health.

The presence of COPD is therefore part of the treatment picture rather than a reason to assume that effective cancer treatment is not possible.

Why Lung Function Testing Matters After a Cancer Diagnosis

Once lung cancer has been diagnosed, pulmonary function tests can provide information that imaging cannot.

Spirometry can identify and measure airflow obstruction, while additional tests can assess lung volumes and how efficiently gases move between the lungs and bloodstream.

These results can help establish how much respiratory reserve a patient has before treatment. They may be particularly important when surgery or thoracic radiotherapy is being considered.

There is therefore an important difference between using spirometry to diagnose cancer and using it to help plan cancer treatment. The first is not possible; the second can be extremely useful.

The role of spirometry in lung cancer care includes assessing baseline lung function, identifying COPD and helping determine suitability for certain treatments.

Can Stopping Smoking Still Make a Difference?

Yes. If someone currently smokes, stopping remains worthwhile even after COPD or lung cancer has been diagnosed.

Stopping smoking reduces continued exposure to the substances responsible for further lung damage. For someone with COPD, stopping smoking is one of the most important steps they can take to reduce continued tobacco-related damage to the lungs.

It can also be relevant when cancer treatment is being planned. Protecting the lung function that remains is particularly important when the lungs may already have been affected by COPD and are about to undergo surgery, radiotherapy or another intensive treatment.

There is no point at which someone should feel that they have smoked for too long for stopping to matter.

Reducing tobacco exposure is only one part of the wider picture. Lung cancer prevention also involves considering occupational exposures, radon, air pollution and appropriate monitoring for people at increased risk.

When a Second Opinion May Be Helpful

Treatment decisions can become more complicated when lung cancer occurs alongside significant COPD.

There may be questions about whether surgery is safe, whether radiotherapy can be delivered appropriately, or how the balance between cancer control and respiratory function should influence treatment.

A second opinion can be useful when you want another specialist assessment of an established diagnosis and proposed treatment plan, particularly if several approaches are being considered.

The purpose is not necessarily to change the recommendation. It may instead provide greater clarity about why a particular approach has been advised and how existing COPD has been taken into account.

COPD and Lung Cancer: What Should Patients Remember?

COPD and lung cancer are separate diseases, but their relationship matters.

They share major risk factors, and COPD is associated with an increased risk of lung cancer. Their symptoms can also overlap, which means new or changing respiratory symptoms should not automatically be assumed to be part of established COPD.

If lung cancer is diagnosed, having COPD does not mean treatment is impossible. Lung function, cancer stage, tumour type, general health and the proposed treatment all need to be considered together.

For patients facing these decisions, speaking with a private oncology consultant can help put the cancer diagnosis, respiratory health and available treatment options into clearer context.

About Dr James Wilson

COPD can add another layer of complexity to lung cancer treatment, particularly when decisions involve surgery, radiotherapy or other treatments that need to be considered alongside existing respiratory function.

Dr James Wilson is a consultant clinical oncologist in full-time private practice in Central London, specialising in lung cancer and advanced radiotherapy. His approach is centred on clear, consultant-led care, helping patients understand their treatment options and access specialist advice promptly, without unnecessary delays.